A look at GM's payback plan, with CNBC's Phil LeBeau and Ally Bank's strategy with Ed Yingling, The American Bankers Association president/CEO.
Mad Money host Jim Cramer gives his take on the market.
The Fast Money team discusses the mid-day market action, with CNBC's Melissa Lee.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. CNBC's Mike Huckman has the details.
Fed Chairman Ben Bernanke discusses the economy and employment in front of the members of the Economic Club of New York.
Abbott Laboratories' Niaspan beat Merck's Zetia in a new study. Dr. Steven Nissen, chairman of the Department of Cardiovascular Medicine at The Cleveland Clinic, shares his reaction with CNBC's Mike Huckman.
The US and China together generate roughly 40 percent of the global emissions and use one third of the world's energy, but now both countries are making a big push to go green, reports CNBC's John Harwood.
A new study is putting Merck's cholesterol drugs under pressure today, reports CNBC's Mike Huckman, with Ken Frazier, Merck Global Human Health president.
Robert Doll, vice chairman of BlackRock, shares his outlook on the markets.
President Obama says China and US are not pre-destined adversaries. CNBC's John Harwood has the details on President Obama's visit to China.